Pfizer (PFE) and Valneva (VLA FP) announce Lyme Disease vaccine candidate demonstrates strong efficacy in Phase 3 VALOR trial
Every headline is on the live feed 20 minutes before this site.
Russia's Ust-Luga resumed oil and fuel loadings on Monday after the drone alert was lifted, sources suggest
European Commission spokesperson says the EU gas coordination group are to meet on Thursday to discuss the Middle East situation
Pfizer (PFE) and Valneva (VLA FP) announce Lyme Disease vaccine candidate demonstrates strong efficacy in Phase 3 VALOR trial
EU sells EUR 5.731bln vs Exp. 7.0bln 2030, 2033, 2034 NGEU Bonds
India's mines minister says they have taken steps to ensure coal prices should not increase
On the Newsquawk feed at , 20 minutes before this page.
- Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above
- The investigational vaccine candidate was well tolerated with no safety concerns identified at time of analysis
- Overall, results strengthen confidence in the vaccine candidate and Pfizer is planning submissions to regulatory authorities
Context
The positive results from Pfizer and Valneva's Lyme disease vaccine trial highlight a significant advancement in the pharmaceutical sector and could lead to substantial revenue opportunities for both companies. With efficacy above 70% and strong tolerability, this news not only bolsters confidence in the vaccine but also suggests Pfizer's forthcoming regulatory submissions may catalyze market interest and potentially impact stock performance in the biotech space. Overall, this could be a bullish signal for equities tied to COVID-19 and other vaccine developments.
Related headlines
- US Market Wrap: Stocks hit as AI growth concerns weigh on sentiment 7 hours ago
- US BROKER MOVES: CPRI upgrade at Raymond James; WDAY downgraded at KeyBanc15 hours ago
- Newsquawk Daily European Equity Opening News - 16th October 202622 hours ago
- Daily US Equity Opening News: 16th October 2026: TSLA gains on Roadster reveal; NFLX slips as Content Chief to leave; TRV earnings underwhelm15 hours ago
- Mercedes-Benz (MBG GY) expands their partnership with Nvidia (NVDA) for automated driving20 hours ago
- Week in Focus 19-23rd October 2026: Highlights include UK, Japan and Canada inflation, China Activity Data and Global Flash PMIs 7 hours ago
- Nvidia (NVDA) expands tools for building AI-powered games with Unreal Engine 59 hours ago
- CRUDE WRAP: WTI (X6) SETTLES USD 3.44 HIGHER AT USD 101.41/BBL; BRENT (Z6) SETTLES USD 3.94 HIGHER AT USD 109.86/BBL9 hours ago
- US FAA is set to approve certification for the Boeing (BA) 737 MAX 10, sources report; potentially as soon as in the next week10 hours ago
- US President Trump says US economy has never been stronger; regarding oil drilling in Texas, nobody can take a chance on it11 hours ago
- US President Trump says Israel has been helpful to Saudi Arabia11 hours ago
- US President Trump says he wants the Russia/Ukraine war ended; on Zelensky/Ukraine, says at some point I'll release details; I think it's good; will get a deal on nuclear arms with Russia and China11 hours ago
- US President Trump, when asked about the Ukraine starlink slowdown, says i did not slow it down11 hours ago
- Daily US Earnings Estimates: 19th October 2026: FITB, WRB, and STLD11 hours ago
- US officials pressed Beijing on market access issues for Mastercard (MA) and Citigroup (C) during at least two bilateral meetings with Chinese counterparts in Bangkok this week, CNBC reports, citing a source12 hours ago
- Apple (AAPL) set for UK legal fight over iPhone tap-to-pay rules, FT reports12 hours ago
- Meta (META) employees acknowleged in internal communication that President Lula's accounts were affected by restrictions during the Brazil election, according to Folha13 hours ago
- US Midterm Preview: Democrats Favoured to Flip the House, Senate Too Close to Call13 hours ago
- US EQUITY OPEN: Stocks mixed at the open as AI stock rout continues14 hours ago
- Newsquawk Weekly Economic Calendar - 19th-23rd October 202614 hours ago
The feed had this first.
Use the Platform